DRIEHAUS CAPITAL MANAGEMENT LLC 13D/13G Filings for Definium Therapeutics, Inc. (DFTX)

DRIEHAUS CAPITAL MANAGEMENT LLC 13D and 13G filings for Definium Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-14
07:34 am
Purchase
2026-06-3013GDEFINIUM THERAPEUTICS INC
DFTX
DRIEHAUS CAPITAL MANAGEMENT LLC6,845,276
5.360%
308,074increase
(+4.71%)
Filing
2026-02-17
09:22 am
Purchase
2025-12-3113GDEFINIUM THERAPEUTICS INC
DFTX
DRIEHAUS CAPITAL MANAGEMENT LLC6,537,202
6.640%
6,537,202increase
(New Position)
Filing